Oakley J, Hill M, Giess A, Tanguy M, Elgar G
J Transl Med. 2023; 21(1):825.
PMID: 37978513
PMC: 10655400.
DOI: 10.1186/s12967-023-04711-5.
Landini A, Yu S, Gnecchi-Ruscone G, Abondio P, Ojeda-Granados C, Sarno S
Evol Appl. 2021; 14(2):297-313.
PMID: 33664777
PMC: 7896717.
DOI: 10.1111/eva.13090.
Zhu H, Hu Y, Zeng C, Chang L, Ge F, Wang W
Theranostics. 2020; 10(5):2188-2200.
PMID: 32104503
PMC: 7019158.
DOI: 10.7150/thno.39151.
Murray J, Mesaros C, Arlt V, Seidel A, Blair I, Penning T
Chem Res Toxicol. 2018; 31(11):1277-1288.
PMID: 30406992
PMC: 6319660.
DOI: 10.1021/acs.chemrestox.8b00250.
Penning T, Wangtrakuldee P, Auchus R
Endocr Rev. 2018; 40(2):447-475.
PMID: 30137266
PMC: 6405412.
DOI: 10.1210/er.2018-00089.
Cancer stem cell-related marker expression in lung adenocarcinoma and relevance of histologic subtypes based on IASLC/ATS/ERS classification.
Shimada Y, Saji H, Nomura M, Matsubayashi J, Yoshida K, Kakihana M
Onco Targets Ther. 2013; 6:1597-604.
PMID: 24235845
PMC: 3825709.
DOI: 10.2147/OTT.S52353.
Expression of aldo-keto reductase family 1 member C3 (AKR1C3) in neuroendocrine tumors & adenocarcinomas of pancreas, gastrointestinal tract, and lung.
Chang T, Lin H, Rogers K, Brame L, Yeh M, Yang Q
Int J Clin Exp Pathol. 2013; 6(11):2419-29.
PMID: 24228104
PMC: 3816811.
The Role of Human Aldo-Keto Reductases in the Metabolic Activation and Detoxication of Polycyclic Aromatic Hydrocarbons: Interconversion of PAH Catechols and PAH o-Quinones.
Zhang L, Jin Y, Huang M, Penning T
Front Pharmacol. 2012; 3:193.
PMID: 23162467
PMC: 3499756.
DOI: 10.3389/fphar.2012.00193.
Differential expression of type 2 3α/type 5 17β-hydroxysteroid dehydrogenase (AKR1C3) in tumors of the central nervous system.
Park A, Lin H, Yang Q, Sing C, Fan M, Mapstone T
Int J Clin Exp Pathol. 2010; 3(8):743-54.
PMID: 21151387
PMC: 2993224.
Elevated AKR1C3 expression promotes prostate cancer cell survival and prostate cell-mediated endothelial cell tube formation: implications for prostate cancer progression.
Dozmorov M, Azzarello J, Wren J, Fung K, Yang Q, Davis J
BMC Cancer. 2010; 10:672.
PMID: 21134280
PMC: 3013086.
DOI: 10.1186/1471-2407-10-672.
Suppressed expression of type 2 3alpha/type 5 17beta-hydroxysteroid dehydrogenase (AKR1C3) in endometrial hyperplasia and carcinoma.
Zakharov V, Lin H, Azzarello J, McMeekin S, Moore K, Penning T
Int J Clin Exp Pathol. 2010; 3(6):608-17.
PMID: 20661409
PMC: 2907123.
Expression of AKR1C3 in renal cell carcinoma, papillary urothelial carcinoma, and Wilms' tumor.
Azzarello J, Lin H, Gherezghiher A, Zakharov V, Yu Z, Kropp B
Int J Clin Exp Pathol. 2010; 3(2):147-55.
PMID: 20126582
PMC: 2809994.
Tissue distribution of human AKR1C3 and rat homolog in the adult genitourinary system.
Azzarello J, Fung K, Lin H
J Histochem Cytochem. 2008; 56(9):853-61.
PMID: 18574251
PMC: 2516960.
DOI: 10.1369/jhc.2008.951384.
An indomethacin analogue, N-(4-chlorobenzoyl)-melatonin, is a selective inhibitor of aldo-keto reductase 1C3 (type 2 3alpha-HSD, type 5 17beta-HSD, and prostaglandin F synthase), a potential target for the treatment of hormone dependent and hormone....
Byrns M, Steckelbroeck S, Penning T
Biochem Pharmacol. 2007; 75(2):484-93.
PMID: 17950253
PMC: 2245880.
DOI: 10.1016/j.bcp.2007.09.008.
Structural elucidation of chalcone reductase and implications for deoxychalcone biosynthesis.
Bomati E, Austin M, Bowman M, Dixon R, Noel J
J Biol Chem. 2005; 280(34):30496-503.
PMID: 15970585
PMC: 2860619.
DOI: 10.1074/jbc.M502239200.
Aldo-keto reductases and formation of polycyclic aromatic hydrocarbon o-quinones.
Penning T
Methods Enzymol. 2004; 378:31-67.
PMID: 15038957
PMC: 2561330.
DOI: 10.1016/S0076-6879(04)78003-9.
Co-operative regulation of the transcription of human dihydrodiol dehydrogenase (DD)4/aldo-keto reductase (AKR)1C4 gene by hepatocyte nuclear factor (HNF)-4alpha/gamma and HNF-1alpha.
Ozeki T, Takahashi Y, Kume T, Nakayama K, Yokoi T, Nunoya K
Biochem J. 2001; 355(Pt 2):537-44.
PMID: 11284743
PMC: 1221767.
DOI: 10.1042/0264-6021:3550537.
Human 3alpha-hydroxysteroid dehydrogenase isoforms (AKR1C1-AKR1C4) of the aldo-keto reductase superfamily: functional plasticity and tissue distribution reveals roles in the inactivation and formation of male and female sex hormones.
Penning T, Burczynski M, Jez J, Hung C, Lin H, Ma H
Biochem J. 2000; 351(Pt 1):67-77.
PMID: 10998348
PMC: 1221336.
DOI: 10.1042/0264-6021:3510067.
Selective serotonin reuptake inhibitors directly alter activity of neurosteroidogenic enzymes.
Griffin L, Mellon S
Proc Natl Acad Sci U S A. 1999; 96(23):13512-7.
PMID: 10557352
PMC: 23979.
DOI: 10.1073/pnas.96.23.13512.
Major differences exist in the function and tissue-specific expression of human aflatoxin B1 aldehyde reductase and the principal human aldo-keto reductase AKR1 family members.
OConnor T, Ireland L, Harrison D, Hayes J
Biochem J. 1999; 343 Pt 2:487-504.
PMID: 10510318
PMC: 1220579.